Background: Cancer remains one of the leading causes of death. Over the past decade, discovery of tumor antigens, as well as new findings in basic immunology, have led to novel opportunities for developing active immunotherapeutical approaches for prevention and treatment of cancer. Objective/methods: This is a review of the literature and patents on the therapeutic potential of immune-based cell cancer therapies. Results/conclusion: In this article, we discuss the different approaches at present used for immune-based cell cancer therapies, and the results obtained both in preclinical models and in clinical trials of hematological malignancies and solid tumors
Cancer immunotherapy has dramatically changed the approach to cancer treatment. The aim of targeting...
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. The search for an effective drug to treat ...
BACKGROUND AIMS: The field of cell and gene therapy in oncology has moved rapidly since 2017 when th...
Background: Cancer remains one of the leading causes of death. Over the past decade, discovery of tu...
Cancer cells have developed numerous ways to escape immune surveillance and gain unlimited prolifera...
BACKGROUND: For 50 years, cancer physicians have relied on just three primary treatment modalities: ...
Immunotherapy has changed the environment of cancer treatment by providing new and efficacious thera...
Recent work has suggested involvement of the immune system in biological therapies specifically targ...
Harnessing the potential of the human body's own immune system to attack malignant tumor cells has b...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer immunotherapy has come a long way. The hope that immunological approaches may help cancer pat...
Cancer is a condition that has plagued humanity for thousands of years, with the first depictions da...
The concept of cancer immunotherapy stems from the proposed function of the immune system, called im...
Immunotherapy in cancer takes advantage of the exquisite specificity, potency, and flexibility of th...
The possibility of using the immune system of patients to control tumor outgrowth in a therapeutic s...
Cancer immunotherapy has dramatically changed the approach to cancer treatment. The aim of targeting...
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. The search for an effective drug to treat ...
BACKGROUND AIMS: The field of cell and gene therapy in oncology has moved rapidly since 2017 when th...
Background: Cancer remains one of the leading causes of death. Over the past decade, discovery of tu...
Cancer cells have developed numerous ways to escape immune surveillance and gain unlimited prolifera...
BACKGROUND: For 50 years, cancer physicians have relied on just three primary treatment modalities: ...
Immunotherapy has changed the environment of cancer treatment by providing new and efficacious thera...
Recent work has suggested involvement of the immune system in biological therapies specifically targ...
Harnessing the potential of the human body's own immune system to attack malignant tumor cells has b...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer immunotherapy has come a long way. The hope that immunological approaches may help cancer pat...
Cancer is a condition that has plagued humanity for thousands of years, with the first depictions da...
The concept of cancer immunotherapy stems from the proposed function of the immune system, called im...
Immunotherapy in cancer takes advantage of the exquisite specificity, potency, and flexibility of th...
The possibility of using the immune system of patients to control tumor outgrowth in a therapeutic s...
Cancer immunotherapy has dramatically changed the approach to cancer treatment. The aim of targeting...
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. The search for an effective drug to treat ...
BACKGROUND AIMS: The field of cell and gene therapy in oncology has moved rapidly since 2017 when th...